• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

SUZUKI Fumitaka  鈴木 文孝

ORCIDConnect your ORCID iD *help
… Alternative Names

鈴木 文孝  スズキ フミタカ

Less
Researcher Number 80322642
Affiliation (Current) 2026: (財)冲中記念成人病研究所, その他部局等, 研究員
Affiliation (based on the past Project Information) *help 2012 – 2014: 公益財団法人冲中記念成人病研究所, その他部局等, 研究員
Review Section/Research Field
Principal Investigator
Gastroenterology
Keywords
Principal Investigator
B型肝炎 / 次世代シークエンサー / 多剤耐性ウイルス / テノホビル / エンテカビル / アデホビル / ラミブジン / B型肝炎
  • Research Projects

    (1 results)
  • Research Products

    (7 results)
  •  Emergence of multidrug resistance in patients with chronic hepatitis B treated by combination therapy with adefovir plus lamivudine or entecavir monotherapy and efficacy of tenofovir therapy.Principal Investigator

    • Principal Investigator
      SUZUKI Fumitaka
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Gastroenterology
    • Research Institution
      Okinaka Memorial Institute for Medical Research

All 2015 2014 2013 2012

All Journal Article Presentation Book

  • [Book] HEPATOLOGY PRACTICE 第1巻 B型肝炎の診療を極める2013

    • Author(s)
      鈴木 文孝
    • Total Pages
      205
    • Publisher
      文光堂
    • Data Source
      KAKENHI-PROJECT-24590999
  • [Journal Article] Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir.2014

    • Author(s)
      Suzuki F,Sezaki H,Akuta N,Suzuki Y,Kawamura Y,Hosaka T,Kobayashi M,Saitoh S,Arase Y,Ikeda K,Kobayashi M,Watahiki S,Mineta R,Suzki Y,Kumada H.
    • Journal Title

      Durug Desgin, Development and Therapy

      Volume: 8 Pages: 869-873

    • DOI

      10.2147/dddt.s65349

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-24590999
  • [Journal Article] Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine.2014

    • Author(s)
      Suzuki F, Hosaka T, Suzuki Y, Akuta N, Sezaki H, Hara T, Kawamura Y, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Watahiki S, Mineta R, Kumada H.
    • Journal Title

      J Gastroenterol

      Volume: 49 Issue: 6 Pages: 1094-1104

    • DOI

      10.1007/s00535-013-0864-4

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-24590999
  • [Presentation] B型慢性肝疾患の核酸アナログ治療における不応例の検討とテノホビルの治療成績2015

    • Author(s)
      鈴木文孝
    • Organizer
      第51回日本肝臓学会総会
    • Place of Presentation
      熊本
    • Year and Date
      2015-05-22
    • Data Source
      KAKENHI-PROJECT-24590999
  • [Presentation] B型慢性肝疾患に対するテノホビル治療の効果と耐性ウイルスの検討2014

    • Author(s)
      鈴木文孝
    • Organizer
      第40回日本肝臓学会東部会
    • Place of Presentation
      東京
    • Year and Date
      2014-11-27
    • Data Source
      KAKENHI-PROJECT-24590999
  • [Presentation] B型慢性肝炎治療におけるHBs抗原陰性化に関する検討2013

    • Author(s)
      鈴木 文孝
    • Organizer
      第49回日本肝臓学会総会
    • Place of Presentation
      東京 京王プラザホテル
    • Data Source
      KAKENHI-PROJECT-24590999
  • [Presentation] B型慢性肝炎の最近の治療2012

    • Author(s)
      鈴木 文孝
    • Organizer
      日本肝臓学会 前期教育講演会
    • Place of Presentation
      金沢市
    • Invited
    • Data Source
      KAKENHI-PROJECT-24590999

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi